Abstract
Given the potentially severe consequences of the metabolic and cardiovascular adverse events often induced by the long-term use of systemic glucocorticoids, it is essential that patients receive adequate screening, preventative care and treatment. However, as data are currently limited and largely inconclusive, medical consensus and optimal management strategies have yet to be established; further study is needed.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
